Company Performance: MRK.MX's stock price is influenced by Merck's financial results like revenue, profit margins, and earnings per share. Positive results can drive the price up, while negative results can push it down.

Pharmaceutical Pipeline: Progress and success of Merck's drug development pipeline significantly impact investor sentiment. Positive clinical trial results and new drug approvals typically lead to stock price appreciation.

Market Conditions: Overall health of the Mexican stock market (BMV) and global economic conditions affect investor appetite for MRK.MX. A bullish market usually favors price increase, while bearish markets may hurt it.

Competitor Activity: Actions of competing pharmaceutical companies, such as new drug launches or acquisitions, can impact MRK.MX's market share and stock price. Competition usually creates downward pressure.

Regulatory Environment: Changes in pharmaceutical regulations in Mexico and globally can impact Merck's operations and profitability, thereby influencing the stock price. Strict regulation could decrease pricing.

Currency Exchange Rates: Fluctuations in the Mexican Peso (MXN) against other currencies, particularly the US dollar, can impact the value of MRK.MX for foreign investors. Devaluation could impact returns.

Investor Sentiment: General investor mood and confidence in Merck's management and future prospects significantly influence buying and selling pressure, thereby affecting the stock price. Positive sentiment causes a rise.

Industry Trends: Trends in the pharmaceutical industry, such as the growth of biosimilars or personalized medicine, affect investors' perceptions of Merck's long-term viability, influencing the stock price. Innovation is key.